Aiforia Technologies Plc, Press Release October 17, 2024 at 14:15 p.m. EEST

Aiforia selected as a vendor for the novel NIH STRIDES Google Marketplace

Google Public Sector, in partnership with the National Institutes of Health (NIH), Carahsoft Technology Corporation, and 11 independent software vendors, announced the launch of a specially curated Google Cloud Marketplace as part of the NIH’s Science and Technology Research Infrastructure for Discovery, Experimentation, and Sustainability (STRIDES) initiative. Aiforia is one of the featured vendors at the Marketplace and the only one offering AI-based solutions for image analysis.

The NIH STRIDES initiative is a long-term collaboration with Google Cloud and other cloud service providers, designed to build a nationwide biomedical research ecosystem. This initiative offers researchers access to advanced computing resources, data, and tools to support their work. Through the "NIH STRIDES Google Cloud Marketplace," researchers and scientists can easily browse, acquire, and implement cloud-based tools and services from Google Cloud partners, helping to speed up their research and discoveries. The NIH STRIDES Google Cloud Marketplace offers discounted rates to eligible researchers, leveraging Carahsoft’s Other Transaction Agreement (OTA) contract in support of the NIH STRIDES initiative.

“We are excited to be a part of the NIH STRIDES initiative and to help researchers make the most of our advanced AI development tool. Aiforia®️ Create has been designed especially for pathologists and scientists aiming to make discoveries from image data and to open new avenues based on quantitative information. This marketplace opens us a new channel to reach the leading research community in the US,” says Jukka Tapaninen, CEO of Aiforia.

NIH issues annual grants to academic universities, hospitals, small businesses, and other organizations throughout the U.S. and internationally. In 2023, NIH awarded 11,052 research project grants with USD 25,365 billion. The average size of research project grants was USD 609,790.

Further inquiries

Jukka Tapaninen, CEO, Aiforia Technologies Plc
tel. +33 61 041 6686
https://investors.aiforia.com/

Certified Adviser 

UB Corporate Finance Ltd
ubcf@unitedbankers.fi

About Aiforia

Aiforia is a trusted provider of deep learning artificial intelligence (AI) solutions for pathology. Aiforia delivers software solutions that elevate diagnostic capabilities in image analysis, enabling remarkable medical discoveries now and in the future. With thousands of AI models already developed on the Aiforia platform for research use and several diagnostic solutions deployed, Aiforia is already significantly impacting pathology and healthcare.

Founded in 2013, Aiforia is a publicly traded company operating internationally with thousands of platform users across the globe. The company is headquartered in Helsinki, Finland, with offices in Cambridge, Massachusetts, and Rochester, Minnesota, and local representatives across Europe and North America. The diverse team at Aiforia includes experienced pathologists, medical scientists, AI and software developers, and a dedicated commercial team. Together, they are working to transform pathology with AI, enabling better care for each patient.

Find out more at www.aiforia.com